Gallstones and the risk of biliary tract cancer: a population-based study in China
We conducted a population-based study of 627 patients with biliary tract cancers (368 of gallbladder, 191 bile duct, and 68 ampulla of Vater), 1037 with biliary stones, and 959 healthy controls randomly selected from the Shanghai population, all personally interviewed. Gallstone status was based on...
Saved in:
Published in | British journal of cancer Vol. 97; no. 11; pp. 1577 - 1582 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
03.12.2007
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
ISSN | 0007-0920 1532-1827 |
DOI | 10.1038/sj.bjc.6604047 |
Cover
Loading…
Abstract | We conducted a population-based study of 627 patients with biliary tract cancers (368 of gallbladder, 191 bile duct, and 68 ampulla of Vater), 1037 with biliary stones, and 959 healthy controls randomly selected from the Shanghai population, all personally interviewed. Gallstone status was based on information from self-reports, imaging procedures, surgical notes, and medical records. Among controls, a transabdominal ultrasound was performed to detect asymptomatic gallstones. Gallstones removed from cancer cases and gallstone patients were classified by size, weight, colour, pattern, and content of cholesterol, bilirubin, and bile acids. Of the cancer patients, 69% had gallstones compared with 23% of the population controls. Compared with subjects without gallstones, odds ratios associated with gallstones were 23.8 (95% confidence interval (CI), 17.0–33.4), 8.0 (95% CI 5.6–11.4), and 4.2 (95% CI 2.5–7.0) for cancers of the gallbladder, extrahepatic bile ducts, and ampulla of Vater, respectively, persisting when restricted to those with gallstones at least 10 years prior to cancer. Biliary cancer risks were higher among subjects with both gallstones and self-reported cholecystitis, particularly for gallbladder cancer (OR=34.3, 95% CI 19.9–59.2). Subjects with bile duct cancer were more likely to have pigment stones, and with gallbladder cancer to have cholesterol stones (
P
<0.001). Gallstone weight in gallbladder cancer was significantly higher than in gallstone patients (4.9
vs
2.8 grams;
P
=0.001). We estimate that in Shanghai 80% (95% CI 75–84%), 59% (56–61%), and 41% (29–59%) of gallbladder, bile duct, and ampulla of Vater cancers, respectively, could be attributed to gallstones. |
---|---|
AbstractList | We conducted a population-based study of 627 patients with biliary tract cancers (368 of gallbladder, 191 bile duct, and 68 ampulla of Vater), 1037 with biliary stones, and 959 healthy controls randomly selected from the Shanghai population, all personally interviewed. Gallstone status was based on information from self-reports, imaging procedures, surgical notes, and medical records. Among controls, a transabdominal ultrasound was performed to detect asymptomatic gallstones. Gallstones removed from cancer cases and gallstone patients were classified by size, weight, colour, pattern, and content of cholesterol, bilirubin, and bile acids. Of the cancer patients, 69% had gallstones compared with 23% of the population controls. Compared with subjects without gallstones, odds ratios associated with gallstones were 23.8 (95% confidence interval (CI), 17.0–33.4), 8.0 (95% CI 5.6–11.4), and 4.2 (95% CI 2.5–7.0) for cancers of the gallbladder, extrahepatic bile ducts, and ampulla of Vater, respectively, persisting when restricted to those with gallstones at least 10 years prior to cancer. Biliary cancer risks were higher among subjects with both gallstones and self-reported cholecystitis, particularly for gallbladder cancer (OR=34.3, 95% CI 19.9–59.2). Subjects with bile duct cancer were more likely to have pigment stones, and with gallbladder cancer to have cholesterol stones (
P
<0.001). Gallstone weight in gallbladder cancer was significantly higher than in gallstone patients (4.9
vs
2.8 grams;
P
=0.001). We estimate that in Shanghai 80% (95% CI 75–84%), 59% (56–61%), and 41% (29–59%) of gallbladder, bile duct, and ampulla of Vater cancers, respectively, could be attributed to gallstones. We conducted a population-based study of 627 patients with biliary tract cancers (368 of gallbladder, 191 bile duct, and 68 ampulla of Vater), 1037 with biliary stones, and 959 healthy controls randomly selected from the Shanghai population, all personally interviewed. Gallstone status was based on information from self-reports, imaging procedures, surgical notes, and medical records. Among controls, a transabdominal ultrasound was performed to detect asymptomatic gallstones. Gallstones removed from cancer cases and gallstone patients were classified by size, weight, colour, pattern, and content of cholesterol, bilirubin, and bile acids. Of the cancer patients, 69% had gallstones compared with 23% of the population controls. Compared with subjects without gallstones, odds ratios associated with gallstones were 23.8 (95% confidence interval (CI), 17.0-33.4), 8.0 (95% CI 5.6-11.4), and 4.2 (95% CI 2.5-7.0) for cancers of the gallbladder, extrahepatic bile ducts, and ampulla of Vater, respectively, persisting when restricted to those with gallstones at least 10 years prior to cancer. Biliary cancer risks were higher among subjects with both gallstones and self-reported cholecystitis, particularly for gallbladder cancer (OR=34.3, 95% CI 19.9-59.2). Subjects with bile duct cancer were more likely to have pigment stones, and with gallbladder cancer to have cholesterol stones (P<0.001). Gallstone weight in gallbladder cancer was significantly higher than in gallstone patients (4.9 vs 2.8 grams; P=0.001). We estimate that in Shanghai 80% (95% CI 75-84%), 59% (56-61%), and 41% (29-59%) of gallbladder, bile duct, and ampulla of Vater cancers, respectively, could be attributed to gallstones.We conducted a population-based study of 627 patients with biliary tract cancers (368 of gallbladder, 191 bile duct, and 68 ampulla of Vater), 1037 with biliary stones, and 959 healthy controls randomly selected from the Shanghai population, all personally interviewed. Gallstone status was based on information from self-reports, imaging procedures, surgical notes, and medical records. Among controls, a transabdominal ultrasound was performed to detect asymptomatic gallstones. Gallstones removed from cancer cases and gallstone patients were classified by size, weight, colour, pattern, and content of cholesterol, bilirubin, and bile acids. Of the cancer patients, 69% had gallstones compared with 23% of the population controls. Compared with subjects without gallstones, odds ratios associated with gallstones were 23.8 (95% confidence interval (CI), 17.0-33.4), 8.0 (95% CI 5.6-11.4), and 4.2 (95% CI 2.5-7.0) for cancers of the gallbladder, extrahepatic bile ducts, and ampulla of Vater, respectively, persisting when restricted to those with gallstones at least 10 years prior to cancer. Biliary cancer risks were higher among subjects with both gallstones and self-reported cholecystitis, particularly for gallbladder cancer (OR=34.3, 95% CI 19.9-59.2). Subjects with bile duct cancer were more likely to have pigment stones, and with gallbladder cancer to have cholesterol stones (P<0.001). Gallstone weight in gallbladder cancer was significantly higher than in gallstone patients (4.9 vs 2.8 grams; P=0.001). We estimate that in Shanghai 80% (95% CI 75-84%), 59% (56-61%), and 41% (29-59%) of gallbladder, bile duct, and ampulla of Vater cancers, respectively, could be attributed to gallstones. We conducted a population-based study of 627 patients with biliary tract cancers (368 of gallbladder, 191 bile duct, and 68 ampulla of Vater), 1037 with biliary stones, and 959 healthy controls randomly selected from the Shanghai population, all personally interviewed. Gallstone status was based on information from self-reports, imaging procedures, surgical notes, and medical records. Among controls, a transabdominal ultrasound was performed to detect asymptomatic gallstones. Gallstones removed from cancer cases and gallstone patients were classified by size, weight, colour, pattern, and content of cholesterol, bilirubin, and bile acids. Of the cancer patients, 69% had gallstones compared with 23% of the population controls. Compared with subjects without gallstones, odds ratios associated with gallstones were 23.8 (95% confidence interval (CI), 17.0-33.4), 8.0 (95% CI 5.6-11.4), and 4.2 (95% CI 2.5-7.0) for cancers of the gallbladder, extrahepatic bile ducts, and ampulla of Vater, respectively, persisting when restricted to those with gallstones at least 10 years prior to cancer. Biliary cancer risks were higher among subjects with both gallstones and self-reported cholecystitis, particularly for gallbladder cancer (OR = 34.3, 95% CI 19.9-59.2). Subjects with bile duct cancer were more likely to have pigment stones, and with gallbladder cancer to have cholesterol stones (P < 0.001). Gallstone weight in gallbladder cancer was significantly higher than in gallstone patients (4.9 vs 2.8 grams; P = 0.001). We estimate that in Shanghai 80% (95% CI 75-84%), 59% (56-61%), and 41% (29-59%) of gallbladder, bile duct, and ampulla of Vater cancers, respectively, could be attributed to gallstones. |
Author | Hsing, A W Zhang, B-H Shen, M-C Gao, Y-T Chen, J Niwa, S Rashid, A Sakoda, L C Han, T-Q Wang, B-S Fraumeni, J F |
Author_xml | – sequence: 1 givenname: A W surname: Hsing fullname: Hsing, A W email: hsinga@mail.nih.gov organization: Division of Cancer Epidemiology and Genetics, National Cancer Institute – sequence: 2 givenname: Y-T surname: Gao fullname: Gao, Y-T organization: Shanghai Cancer Institute – sequence: 3 givenname: T-Q surname: Han fullname: Han, T-Q organization: Ruijin Hospital, Shanghai Second Medical University – sequence: 4 givenname: A surname: Rashid fullname: Rashid, A organization: Department of Pathology, University of Texas MD Anderson Cancer Center – sequence: 5 givenname: L C surname: Sakoda fullname: Sakoda, L C organization: Department of Epidemiology, University of Washington, Seattle, WA 98195 – sequence: 6 givenname: B-S surname: Wang fullname: Wang, B-S organization: Zhongshan Hospital, Fudan University – sequence: 7 givenname: M-C surname: Shen fullname: Shen, M-C organization: Shanghai Tumor Hospital – sequence: 8 givenname: B-H surname: Zhang fullname: Zhang, B-H organization: Institute of Oriental Hepatobiliary Surgery, Second Military Medical University – sequence: 9 givenname: S surname: Niwa fullname: Niwa, S organization: Westat Inc – sequence: 10 givenname: J surname: Chen fullname: Chen, J organization: University of Pennsylvania – sequence: 11 givenname: J F surname: Fraumeni fullname: Fraumeni, J F organization: Division of Cancer Epidemiology and Genetics, National Cancer Institute |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19977624$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/18000509$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkt9rFDEQx4NU7LX66qMEwb7tdZLd_FgfBDlqFQqC6HPIJtlezlxyJrtC_3ujd3paKD6EZMjn-81kZs7QSUzRIfScwJJAKy_LZjlszJJz6KATj9CCsJY2RFJxghYAIBroKZyis1I2NexBiifolMh6ZtAv0KdrHUKZqmnBOlo8rR3OvnzFacSDD17nOzxlbSZsdDQuv8Ya79JuDnryKTaDLs7iMs32DvuIV2sf9VP0eNShuGeH_Rx9eXf1efW-ufl4_WH19qYxTNKpYYz3sucjEZppYyl30upxZLodZF3WciADtYYKxztrWCdrBNCCc1KQnrTn6M3edzcPW2eNizXRoHbZb2vWKmmv_r2Jfq1u03dFWw6UiWpwcTDI6dvsyqS2vhgXgo4uzUVxyTrBWvlfkAIjHNq2gi_vgZs051irUB8FoJwTWqEXf-f9J-HfTanAqwOgi9FhzLXyvhy5vheC065yyz1nciolu_GIgPo5HapsVJ0OdZiOKujuCYyffjWy1seHh2WXe1mp_vHW5eOvHlD8ACGLzng |
CODEN | BJCAAI |
CitedBy_id | crossref_primary_10_3390_nu9090950 crossref_primary_10_1007_s10654_015_0081_y crossref_primary_10_1016_j_jhep_2020_11_033 crossref_primary_10_5301_tj_5000397 crossref_primary_10_1111_eci_12185 crossref_primary_10_1016_j_cgh_2017_11_034 crossref_primary_10_1016_S1499_3872_13_60030_2 crossref_primary_10_1097_MD_0000000000022292 crossref_primary_10_1186_1750_9378_6_6 crossref_primary_10_4251_wjgo_v12_i12_1381 crossref_primary_10_1016_S0221_0363_10_70032_9 crossref_primary_10_23736_S0394_9508_21_05327_4 crossref_primary_10_1007_s11377_017_0216_7 crossref_primary_10_1097_CM9_0000000000002258 crossref_primary_10_15388_LietChirur_2024_23_2__3 crossref_primary_10_1007_s12029_019_00347_1 crossref_primary_10_1007_s12029_011_9284_y crossref_primary_10_1093_carcin_bgq194 crossref_primary_10_1007_s11523_024_01086_5 crossref_primary_10_1158_1055_9965_EPI_07_2704 crossref_primary_10_1016_j_canlet_2021_09_004 crossref_primary_10_7314_APJCP_2015_16_7_2923 crossref_primary_10_1038_s41416_022_01877_5 crossref_primary_10_1186_s12885_022_09382_x crossref_primary_10_1038_sj_bjc_6604616 crossref_primary_10_1186_s12014_023_09399_9 crossref_primary_10_9738_INTSURG_D_18_00013_1 crossref_primary_10_1155_2023_8104679 crossref_primary_10_1186_1756_9966_30_2 crossref_primary_10_1136_gutjnl_2018_317504 crossref_primary_10_5009_gnl_2012_6_2_172 crossref_primary_10_4143_crt_2017_279 crossref_primary_10_1016_j_mrrev_2011_06_002 crossref_primary_10_1038_sj_bjc_6605706 crossref_primary_10_1007_s13193_012_0150_6 crossref_primary_10_4178_epih_e2021011 crossref_primary_10_1093_jnci_djz103 crossref_primary_10_3390_cancers13051186 crossref_primary_10_1111_jgh_14054 crossref_primary_10_1038_bjc_2011_363 crossref_primary_10_1111_jgh_12278 crossref_primary_10_1002_dc_21821 crossref_primary_10_1002_hep_30861 crossref_primary_10_1158_1055_9965_EPI_20_0919 crossref_primary_10_1016_j_jfma_2024_09_010 crossref_primary_10_1016_j_suronc_2010_09_003 crossref_primary_10_1371_journal_pone_0070265 crossref_primary_10_7314_APJCP_2015_16_14_5647 crossref_primary_10_1016_j_ejso_2020_03_222 crossref_primary_10_1158_1055_9965_EPI_07_2735 crossref_primary_10_1016_j_suc_2014_01_009 crossref_primary_10_1016_j_gcb_2008_09_009 crossref_primary_10_1186_s12876_020_01312_0 crossref_primary_10_31146_1682_8658_ecg_205_9_153_160 crossref_primary_10_1016_j_cyto_2016_05_003 crossref_primary_10_1016_j_cyto_2015_01_033 crossref_primary_10_3390_medicina61030452 crossref_primary_10_1007_s00423_015_1300_4 crossref_primary_10_1007_s11864_013_0237_5 crossref_primary_10_1080_0284186X_2018_1549367 crossref_primary_10_1155_2019_1389289 crossref_primary_10_18231_j_jdpo_2020_070 crossref_primary_10_3748_wjg_v21_i12_3679 crossref_primary_10_1002_ijc_34794 crossref_primary_10_1016_S0716_8640_11_70454_0 crossref_primary_10_3390_ijerph192416625 crossref_primary_10_3390_cancers15153880 crossref_primary_10_1186_s12944_025_02472_2 crossref_primary_10_1371_journal_pone_0173935 crossref_primary_10_1002_ijc_23307 crossref_primary_10_1093_carcin_bgp024 crossref_primary_10_1097_HEP_0000000000000748 crossref_primary_10_1186_s12885_015_1870_0 crossref_primary_10_1002_mc_20641 crossref_primary_10_1111_j_1365_2559_2008_03192_x crossref_primary_10_15279_kpba_2022_27_3_121 crossref_primary_10_1111_hel_12457 crossref_primary_10_1038_srep18160 crossref_primary_10_1111_cbdd_12533 crossref_primary_10_1371_journal_pone_0069981 crossref_primary_10_1016_j_canep_2018_03_004 crossref_primary_10_3390_biom14060676 crossref_primary_10_1186_s12944_021_01523_8 crossref_primary_10_1002_ijc_28161 crossref_primary_10_1186_1471_2407_12_468 crossref_primary_10_1177_147323000903700429 crossref_primary_10_1186_1756_9966_28_65 crossref_primary_10_1016_j_yexmp_2011_06_004 crossref_primary_10_3389_fphys_2022_888233 crossref_primary_10_1002_jssc_201400638 crossref_primary_10_1016_j_ejso_2010_05_002 crossref_primary_10_1007_s13193_012_0203_x crossref_primary_10_1097_CM9_0000000000003395 crossref_primary_10_1016_j_humpath_2024_07_001 crossref_primary_10_18632_oncotarget_3861 crossref_primary_10_3390_cancers14133093 crossref_primary_10_1038_sj_bjc_6605597 crossref_primary_10_1002_ijc_32952 crossref_primary_10_1016_j_humpath_2010_12_026 crossref_primary_10_1136_gutjnl_2024_333368 crossref_primary_10_1007_s12253_013_9660_y crossref_primary_10_3390_jpm12020234 crossref_primary_10_1007_s10552_011_9802_z crossref_primary_10_1016_j_jdiacomp_2015_11_012 crossref_primary_10_1053_j_gastro_2017_04_005 crossref_primary_10_1093_aje_kwt322 crossref_primary_10_1038_s41572_022_00398_y crossref_primary_10_1371_journal_pone_0016449 crossref_primary_10_1111_jgh_15759 crossref_primary_10_1007_s13193_021_01480_9 crossref_primary_10_18410_jebmh_2017_1166 crossref_primary_10_1016_j_jpha_2023_06_003 crossref_primary_10_1111_jgh_14265 crossref_primary_10_7759_cureus_28260 crossref_primary_10_1007_s10147_013_0550_9 crossref_primary_10_1080_09637480902970967 crossref_primary_10_7314_APJCP_2013_14_4_2185 crossref_primary_10_1093_carcin_bgq038 crossref_primary_10_3389_fonc_2022_1046974 crossref_primary_10_1007_s13193_021_01455_w crossref_primary_10_1111_j_1478_3231_2009_02149_x crossref_primary_10_1007_s12262_019_02050_8 crossref_primary_10_1016_j_canep_2018_06_004 crossref_primary_10_3390_cancers14051249 crossref_primary_10_1016_j_ijsu_2011_07_001 crossref_primary_10_1186_1477_7819_11_143 crossref_primary_10_1002_gcc_20928 crossref_primary_10_1016_j_mgene_2014_04_012 crossref_primary_10_1016_j_hpb_2019_11_012 crossref_primary_10_1111_ans_18577 crossref_primary_10_2147_IJGM_S297371 crossref_primary_10_3389_fonc_2020_00823 crossref_primary_10_1016_j_rcl_2014_02_011 crossref_primary_10_1016_j_ejca_2011_10_038 crossref_primary_10_3748_wjg_v27_i45_7813 crossref_primary_10_1371_journal_pone_0089368 crossref_primary_10_18632_oncotarget_14815 crossref_primary_10_1186_s12889_019_7160_z crossref_primary_10_3390_cancers2031602 crossref_primary_10_1002_oby_21505 crossref_primary_10_15430_JCP_2020_25_3_164 crossref_primary_10_1177_1553350620950582 crossref_primary_10_12998_wjcc_v10_i29_10399 crossref_primary_10_3390_jpm11121261 crossref_primary_10_1016_j_plipres_2018_06_001 crossref_primary_10_4103_oji_oji_51_20 crossref_primary_10_1002_cbin_11804 crossref_primary_10_1002_hep_32198 crossref_primary_10_1136_gutjnl_2023_331773 crossref_primary_10_1158_0008_5472_CAN_08_0444 crossref_primary_10_1016_S1665_2681_19_31285_2 crossref_primary_10_4103_ijcm_ijcm_796_23 crossref_primary_10_1002_ijc_32863 crossref_primary_10_1186_s12885_020_07139_y crossref_primary_10_46889_JSRP_2023_4305 crossref_primary_10_1007_s00535_012_0683_z crossref_primary_10_1093_annonc_mdn533 crossref_primary_10_1016_j_canrad_2020_06_039 crossref_primary_10_1007_s40137_015_0122_1 crossref_primary_10_1111_j_1445_2197_2009_05033_x crossref_primary_10_1038_s41598_018_23848_8 crossref_primary_10_1016_j_annepidem_2016_08_009 crossref_primary_10_1093_jscr_rjy166 crossref_primary_10_5009_gnl210009 crossref_primary_10_1186_s12876_024_03426_1 crossref_primary_10_4251_wjgo_v11_i3_238 crossref_primary_10_1016_j_soc_2019_06_012 crossref_primary_10_4143_crt_2016_538 crossref_primary_10_1016_j_dld_2010_06_005 crossref_primary_10_3348_jksr_2011_64_3_253 |
Cites_doi | 10.2188/jea.15.S150 10.1016/0009-8981(75)90364-2 10.3322/canjclin.51.6.349 10.7326/0003-4819-107-1-30 10.1097/00000658-199104000-00006 10.1002/(SICI)1097-0215(19980130)75:3<368::AID-IJC7>3.0.CO;2-0 10.2741/A699 10.1002/1097-0142(19950101)75:1+<171::AID-CNCR2820751306>3.0.CO;2-2 10.1001/jama.1983.03340170049027 10.1093/carcin/bgi314 10.1046/j.1440-1622.2000.01926.x 10.1097/00008469-200508000-00011 10.1158/1078-0432.CCR-1137-3 10.1093/clinchem/35.1.173 10.3748/wjg.v4.i1.82 10.1093/jnci/89.15.1132 10.1002/bmc.1130040403 10.1158/1055-9965.EPI-05-0032 10.1093/acprof:oso/9780195149616.003.0040 10.7326/0003-4819-118-3-199302010-00005 10.1016/S0889-8553(21)00531-8 10.1002/1097-0142(19800301)45:5<919::AID-CNCR2820450514>3.0.CO;2-4 |
ContentType | Journal Article |
Copyright | The Author(s) 2007 2008 INIST-CNRS Copyright Nature Publishing Group Dec 3, 2007 Copyright © 2007 Cancer Research UK 2007 Cancer Research UK |
Copyright_xml | – notice: The Author(s) 2007 – notice: 2008 INIST-CNRS – notice: Copyright Nature Publishing Group Dec 3, 2007 – notice: Copyright © 2007 Cancer Research UK 2007 Cancer Research UK |
DBID | C6C AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7RV 7TO 7U9 7X7 7XB 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AN0 AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB0 LK8 M0S M1P M7P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7U1 C1K 7X8 5PM |
DOI | 10.1038/sj.bjc.6604047 |
DatabaseName | Springer Nature OA Free Journals CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland British Nursing Database ProQuest Central Essentials - QC Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences ProQuest Health & Medical Collection Medical Database Biological Science Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Risk Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition British Nursing Index with Full Text ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) Risk Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Risk Abstracts MEDLINE ProQuest Central Student |
Database_xml | – sequence: 1 dbid: C6C name: SpringerOpen Free (Free internet resource, activated by CARLI) url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Gallstones and the risk of biliary tract cancer |
EISSN | 1532-1827 |
EndPage | 1582 |
ExternalDocumentID | PMC2360257 1390227761 18000509 19977624 10_1038_sj_bjc_6604047 |
Genre | Journal Article Research Support, N.I.H., Intramural |
GeographicLocations | Asia China United States--US China, People's Rep., Shanghai China, People's Rep |
GeographicLocations_xml | – name: China – name: United States--US – name: China, People's Rep – name: China, People's Rep., Shanghai |
GrantInformation_xml | – fundername: Intramural NIH HHS |
GroupedDBID | --- -Q- 0R~ 23N 36B 39C 3V. 4.4 406 53G 5GY 5RE 6J9 7RV 7X7 88E 8AO 8C1 8FI 8FJ 8R4 8R5 AANZL AAWTL AAYZH AAZLF ABAKF ABAWZ ABDBF ABLJU ABOCM ABUWG ABZZP ACAOD ACGFO ACGFS ACKTT ACPRK ACRQY ACUHS ACZOJ ADBBV ADFRT ADHDB AEFQL AEJRE AEMSY AENEX AEVLU AFBBN AFKRA AFRAH AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AJRNO ALFFA ALMA_UNASSIGNED_HOLDINGS AMYLF AN0 AOIJS ASPBG AVWKF AXYYD AZFZN B0M BAWUL BBNVY BENPR BHPHI BKEYQ BKKNO BNQBC BPHCQ BVXVI C6C CAG CCPQU COF CS3 DIK DNIVK DPUIP DU5 E3Z EAD EAP EAS EBC EBD EBLON EBS EE. EIOEI EJD EMB EMK EMOBN EPL ESX EX3 F5P FDQFY FEDTE FERAY FIZPM FRJ FSGXE FYUFA GX1 HCIFZ HMCUK HVGLF HYE HZ~ IH2 IWAJR J5H JSO JZLTJ KQ8 M1P M7P NAO NAPCQ NQJWS O9- OK1 P2P PQQKQ PROAC PSQYO Q2X RNT RNTTT ROL RPM SNX SNYQT SOHCF SOJ SRMVM SV3 SWTZT TAOOD TBHMF TDRGL TR2 TUS UKHRP W2D WH7 WOW ~02 ~8M AAFWJ AASML AAYXX ABBRH ABDBE ABFSG ACMFV ACSTC AEZWR AFDZB AFHIU AHWEU AIGIU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT .55 .GJ 70F 8WZ A6W AACDK AATNV ABRTQ AEXYK AI. AILAN FIGPU IQODW M41 PJZUB PPXIY PQGLB UDS VH1 X7M Y6R ZGI CGR CUY CVF ECM EIF NPM 7TO 7U9 7XB 8FE 8FH 8FK AZQEC DWQXO GNUQQ H94 K9. LK8 PKEHL PQEST PQUKI PRINS 7U1 C1K 7X8 5PM |
ID | FETCH-LOGICAL-c582t-5569896f17a5acd26e8daff5a3b8a3bdd601b2dc27e64dc548b2d0030ee871913 |
IEDL.DBID | 7X7 |
ISSN | 0007-0920 |
IngestDate | Thu Aug 21 18:42:46 EDT 2025 Thu Jul 10 17:16:36 EDT 2025 Thu Jul 10 23:11:11 EDT 2025 Fri Jul 25 08:53:06 EDT 2025 Mon Jul 21 06:04:31 EDT 2025 Mon Jul 21 09:12:59 EDT 2025 Tue Jul 01 04:29:24 EDT 2025 Thu Apr 24 23:08:41 EDT 2025 Fri Feb 21 02:43:13 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | biliary tract cancer cholecystitis gallstones China Human Digestive system Bile duct cancer Biliary tract disease Epidemiology Cholelithiasis Cancerology Risk factor Digestive diseases Gallbladder Cholecystitis |
Language | English |
License | http://www.springer.com/tdm CC BY 4.0 This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c582t-5569896f17a5acd26e8daff5a3b8a3bdd601b2dc27e64dc548b2d0030ee871913 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
OpenAccessLink | https://www.nature.com/articles/sj.bjc.6604047 |
PMID | 18000509 |
PQID | 230026612 |
PQPubID | 41855 |
PageCount | 6 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2360257 proquest_miscellaneous_68547538 proquest_miscellaneous_20516033 proquest_journals_230026612 pubmed_primary_18000509 pascalfrancis_primary_19977624 crossref_primary_10_1038_sj_bjc_6604047 crossref_citationtrail_10_1038_sj_bjc_6604047 springer_journals_10_1038_sj_bjc_6604047 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20071203 |
PublicationDateYYYYMMDD | 2007-12-03 |
PublicationDate_xml | – month: 12 year: 2007 text: 20071203 day: 3 |
PublicationDecade | 2000 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: Basingstoke – name: England |
PublicationTitle | British journal of cancer |
PublicationTitleAbbrev | Br J Cancer |
PublicationTitleAlternate | Br J Cancer |
PublicationYear | 2007 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | S Zou (BF6604047_CR31) 2000; 38 AW Hsing (BF6604047_CR12) 2006 J Albores-Saavedra (BF6604047_CR1) 1980; 45 A Maringhini (BF6604047_CR17) 1987; 107 LC Sakoda (BF6604047_CR23) 2006; 27 AK Diehl (BF6604047_CR4) 1983; 250 AW Hsing (BF6604047_CR11) 1998; 75 L Vitetta (BF6604047_CR26) 2000; 70 A Rashid (BF6604047_CR20) 2002; 8 A Swidsinski (BF6604047_CR24) 2001; 6 U Dutts Dutta (BF6604047_CR6) 2005; 14 W Wang (BF6604047_CR28) 2003; 24 E Liu (BF6604047_CR15) 2005; 14 T Ueki (BF6604047_CR25) 2004; 10 A el Zayadi (BF6604047_CR7) 1991; 38 YQ Huang (BF6604047_CR13) 1987; 25 X Zhu (BF6604047_CR30) 1995; 33 EC Lazcano-Ponce (BF6604047_CR14) 2001; 51 K Rothman (BF6604047_CR22) 1998 MT Carriaga (BF6604047_CR2) 1995; 75 TQ Han (BF6604047_CR10) 1998; 4 CH Grimaldi (BF6604047_CR9) 1993; 118 A Oda (BF6604047_CR19) 1975; 64 A Roda (BF6604047_CR21) 1975; 64 T Matsuba (BF6604047_CR18) 2005; 15 GF Wang (BF6604047_CR27) 1990; 4 WA Zatonski (BF6604047_CR29) 1997; 89 AB Lowenfels (BF6604047_CR16) 1985; 75 AK Diehl (BF6604047_CR5) 1991; 20 F Cetta (BF6604047_CR3) 1991; 213 P Fossati (BF6604047_CR8) 1989; 35 |
References_xml | – volume: 15 start-page: S150 issue: Suppl 2 year: 2005 ident: BF6604047_CR18 publication-title: J Epidemiol doi: 10.2188/jea.15.S150 – volume: 64 start-page: 337 year: 1975 ident: BF6604047_CR21 publication-title: Clin Chim Acta doi: 10.1016/0009-8981(75)90364-2 – volume: 51 start-page: 349 year: 2001 ident: BF6604047_CR14 publication-title: CA Cancer J Clin doi: 10.3322/canjclin.51.6.349 – volume: 75 start-page: 77 year: 1985 ident: BF6604047_CR16 publication-title: J Natl Cancer Inst – volume: 8 start-page: 3156 year: 2002 ident: BF6604047_CR20 publication-title: Clin Cancer Res – volume: 107 start-page: 30 year: 1987 ident: BF6604047_CR17 publication-title: Ann Intern Med doi: 10.7326/0003-4819-107-1-30 – volume: 213 start-page: 315 year: 1991 ident: BF6604047_CR3 publication-title: Ann Surg doi: 10.1097/00000658-199104000-00006 – volume: 75 start-page: 368 year: 1998 ident: BF6604047_CR11 publication-title: Int J Cancer doi: 10.1002/(SICI)1097-0215(19980130)75:3<368::AID-IJC7>3.0.CO;2-0 – volume: 6 start-page: E93 year: 2001 ident: BF6604047_CR24 publication-title: Front Biosci doi: 10.2741/A699 – volume: 64 start-page: 337 year: 1975 ident: BF6604047_CR19 publication-title: Clin Chim Acta doi: 10.1016/0009-8981(75)90364-2 – volume: 75 start-page: 171 year: 1995 ident: BF6604047_CR2 publication-title: Cancer doi: 10.1002/1097-0142(19950101)75:1+<171::AID-CNCR2820751306>3.0.CO;2-2 – volume: 250 start-page: 2323 year: 1983 ident: BF6604047_CR4 publication-title: JAMA doi: 10.1001/jama.1983.03340170049027 – volume: 38 start-page: 805 year: 2000 ident: BF6604047_CR31 publication-title: Zhonghua Wai Ke Za Zhi – volume: 27 start-page: 1251 year: 2006 ident: BF6604047_CR23 publication-title: Carcinogenesis doi: 10.1093/carcin/bgi314 – volume: 70 start-page: 667 year: 2000 ident: BF6604047_CR26 publication-title: Aust NZ J Surg doi: 10.1046/j.1440-1622.2000.01926.x – volume: 14 start-page: 381 year: 2005 ident: BF6604047_CR6 publication-title: Eur J Cancer Prev doi: 10.1097/00008469-200508000-00011 – volume: 24 start-page: 272 year: 2003 ident: BF6604047_CR28 publication-title: Zhonghua Liu Xing Bing Xue Za Zhi – volume: 25 start-page: 346 year: 1987 ident: BF6604047_CR13 publication-title: Zhonghua Wai Ke Za Zhi – volume: 10 start-page: 1717 year: 2004 ident: BF6604047_CR25 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-1137-3 – volume: 35 start-page: 173 year: 1989 ident: BF6604047_CR8 publication-title: Clin Chem doi: 10.1093/clinchem/35.1.173 – volume: 4 start-page: 82 year: 1998 ident: BF6604047_CR10 publication-title: World J Gastroenterol doi: 10.3748/wjg.v4.i1.82 – volume: 89 start-page: 1132 year: 1997 ident: BF6604047_CR29 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/89.15.1132 – volume: 4 start-page: 136 year: 1990 ident: BF6604047_CR27 publication-title: Biomed Chromatogr doi: 10.1002/bmc.1130040403 – volume: 38 start-page: 337 year: 1991 ident: BF6604047_CR7 publication-title: Hepatogastroenterology – volume: 14 start-page: 1315 year: 2005 ident: BF6604047_CR15 publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-05-0032 – start-page: 787 volume-title: Cancer Epidemiology and Prevention year: 2006 ident: BF6604047_CR12 doi: 10.1093/acprof:oso/9780195149616.003.0040 – volume: 118 start-page: 185 year: 1993 ident: BF6604047_CR9 publication-title: Ann Intern Med doi: 10.7326/0003-4819-118-3-199302010-00005 – volume-title: Modern Epidemiology year: 1998 ident: BF6604047_CR22 – volume: 33 start-page: 652 year: 1995 ident: BF6604047_CR30 publication-title: Zhonghua Wai Ke Za Zhi – volume: 20 start-page: 1 year: 1991 ident: BF6604047_CR5 publication-title: Gastroenterol Clin North Am doi: 10.1016/S0889-8553(21)00531-8 – volume: 45 start-page: 919 year: 1980 ident: BF6604047_CR1 publication-title: Cancer doi: 10.1002/1097-0142(19800301)45:5<919::AID-CNCR2820450514>3.0.CO;2-4 |
SSID | ssj0009087 |
Score | 2.3608308 |
Snippet | We conducted a population-based study of 627 patients with biliary tract cancers (368 of gallbladder, 191 bile duct, and 68 ampulla of Vater), 1037 with... |
SourceID | pubmedcentral proquest pubmed pascalfrancis crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1577 |
SubjectTerms | Aged Bile Acids and Salts - analysis Bile ducts Biliary Tract - chemistry Biliary Tract - pathology Biliary Tract Neoplasms - epidemiology Bilirubin - analysis Biological and medical sciences Biomedical and Life Sciences Biomedicine Cancer Research China - epidemiology Cholangiocarcinoma Cholesterol - analysis Drug Resistance Epidemiology Female Gallbladder cancer Gallbladder diseases Gallstones Gallstones - metabolism Gallstones - pathology Gastroenterology. Liver. Pancreas. Abdomen Hospitals Humans Liver. Biliary tract. Portal circulation. Exocrine pancreas Male Medical research Medical sciences Middle Aged Molecular Medicine Odds Ratio Oncology Organ Size Other diseases. Semiology Pathology Population Surveillance - methods Population-based studies Risk Factors Skin cancer Tumors |
SummonAdditionalLinks | – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LS-RAEC5WFxZBxH2o8dmHhd1LNNOddHe8yeCDBfewrOAt9CvsDEMcJuPBf29VHjOMq-Ahh9AV0qnqx1ddla8AvjvrbR4EDl4b0EFByBxriz5PUKmxPFdUKZOyLX7Lm7v013123zmKdZdW2VJaNst0nx12Vo9P7didSomDLlVr8JFo2ymFbyiHS5LdRLccmXT8lvOkJ2kU-sXzK5vQ5tTUqI-yLWTxGtL8P2HyRdS02YyutmGrQ5Hsou33Z_gQqi_w6baLk3-FP9dmMiFYF2pmKs8Q5TFKImcPJaNsWDN7YnP6P4o5svrsnBk2XZTyimlr86xhnmWjijU1tr_B3dXl3-FN3FVPiF2m-TzOMqoNKcuBMplxnsugvSnLzAir8fIeXTHLveMqyNQ79FzwjuZ8COhE5QOxA-sV9nMPmFT5oBw45xX3uLAKmwSjHbfK5IL4DCOIe3UWrqMWpwoXk6IJcQtd1OMC1V906o_gx0J-2pJqvCl5vGKdpXiOwFXyNIKD3lxFN_vqAt2qhIAHj-Bk0YrThmIhpgoPjyiCi5FMhHhbQuosRV9OR7DbGn_5bt3S5kSgVobFQoAou1dbqtG_hrqbC4kgEz_rZz-Alr1-XQP77xc9gI3m5JmSbcQhrM9nj-EIIdPcHjfz5BlRfxWT priority: 102 providerName: Springer Nature |
Title | Gallstones and the risk of biliary tract cancer: a population-based study in China |
URI | https://link.springer.com/article/10.1038/sj.bjc.6604047 https://www.ncbi.nlm.nih.gov/pubmed/18000509 https://www.proquest.com/docview/230026612 https://www.proquest.com/docview/20516033 https://www.proquest.com/docview/68547538 https://pubmed.ncbi.nlm.nih.gov/PMC2360257 |
Volume | 97 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEB-0BRFE_DZWz30Q9CVtspvsbnwRPVqLYJFi4d7CfgV7HLnzcn3wv3cmX-dp60MCIQNJZmdnZ3Ymvx_AG2e9LYJA47UBExQMmWNtMecJKjOWF4qYMqnb4kyeXmRfZvms781p-rbKwSe2jtovHe2RH2GonNBiwj-sfsZEGkXF1Z5B4zbsE3IZ5V5qpraYu4nuIDNpN67gyYDZKPRRMz-0c3coJdowMav8sSbdW5kG1VN1vBbXBZ7_9k_-VURt16aTB3C_DyrZx84KHsKtUD-CO1_7svljOP9sFguK8kLDTO0ZBn2MesrZsmLUHGvWv9iGfpdijoxg_Z4ZthqZvWJa6TxrgWjZZc1ayu0ncHFy_H16GvdkCrHLNd_EeU5UkbJKlcmN81wG7U1V5UZYjYf3mJlZ7h1XQWbeYSKDV-QCQsCcqkjFU9ir8T2fA5OqSKvUOa-4Rz8rbBKMdtwqUwiCN4wgHtRZuh5pnAgvFmVb8Ra6bOYlqr_s1R_B21F-1WFs3Cg52RmdrXiBcazkWQQHw3CV_WRsytF0Ing93sVZRKURU4flFYqgb5KJEDdLSJ1nmNrpCJ51g799tu5QdCJQO2YxChCC9-6d-vJHi-TNhcSYEz_r3WBA27e-XgMv_vuBB3C33XumdhvxEvY266vwCoOmjZ20UwPPeppOYP_T8dm3c7yayulvTOsatw |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIgESQrwxhXYPILi4dXbt9RoJIVQoKX0cUCv15u7LolHkhDgV6o_iPzLjVwi03HrIIfIoseex-83OeD6AV9Y4k3mBzms8JigImUNlMOfxaawNz1JiyqRui0M5PI6_niQnK_CrexeG2iq7NbFeqN3E0hn5FkLliDYT_mH6IyTSKCqudgwajVfs-YufmLFV73c_oXlfc77z-Wh7GLakAqFNFJ-HSUKUibIYpDrR1nHpldNFkWhhFH6cwwzFcGd56mXsLAJ6_Eah4D3mFtlA4O_egJuxECmN6lfbi46SLFLNiE46_ct41M2IFGqrGm2akd2UEmOGmFz-2APvTnWF5igaHo3LgO6__Zp_FW3rvXDnPtxrQSz72HjdA1jx5UO4ddCW6R_Bty96PCZU6SumS8cQZDLqYWeTglEzrp5dsDm9nsUsOd3sHdNs2jOJhbSzOlYPvmVnJaspvh_D8bXo-Qmslnifz4DJNBsUA2tdyh2u68JEXivLTaozQeMUAwg7dea2nWxOBBvjvK6wC5VXoxzVn7fqD-BNLz9tZnpcKbm-ZJ2FeIa4WfI4gLXOXHkb_FXeu2oAG_1VjFoqxejST85RBNdCGQlxtYRUSYyppArgaWP8xX-rZmpPAOmSW_QCNDF8-Up59r2eHM6FRIyLj_W2c6DFXV-ugef_fcANuD08OtjP93cP99bgTn3uTa0-4gWszmfn_iUCtrlZr8OEwel1x-VvgPtUqg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIlVICPHGLbR7AMHFTbIb766REEKU0FKoEKJSbu6-LBpFThqnQv1p_Dtm_EgItNx6yCHyKLHnPTvj-QCeO-ttGgQqrw1YoGDKHGuLNU9QfWN5qggpk6YtjuT-cf_TMBmuwa_2XRgaq2x9YuWo_cTRGXkHU-UuBRPeyZupiK97g7fTs5gApKjR2qJp1BpyGC5-YvVWvjnYQ1G_4Hzw4fv7_bgBGIhdovk8ThKCT5R5T5nEOM9l0N7keWKE1fjxHqsVy73jKsi-d5jc4zcyixCwzkh7An_3BtxUAqMmmpIaquW-366u13XSSWDKu-2-SKE75WjXjtyulGg_hOryRzy8PTUliiavMTUuS3r_nd38q4FbxcXBXbjTJLTsXa2B92AtFPdh40vTsn8A3z6a8ZgyzFAyU3iGCSejeXY2yRkN5prZBZvTq1rMkQLOXjPDpgtUsZiirGfVElx2WrAK7vshHF8Lnx_BeoH3-QSYVGkv7znnFffo44XtBqMdt8qkglYrRhC37Mxcs-WcwDbGWdVtFzorRxmyP2vYH8HLBf203u9xJeX2inSW5Cnm0JL3I9hqxZU1jqDMFmobwc7iKlowtWVMESbnSIJ-UXaFuJpC6qSPZaWO4HEt_OV_63qDTwRqRS0WBLQ9fPVKcfqj2iLOhcR8Fx_rVatAy7u-nAOb_33AHdhAi8w-HxwdbsGt6gicpn7EU1ifz87DM8zd5na7shIGJ9dtlr8BkbhZDA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gallstones+and+the+risk+of+biliary+tract+cancer%3A+a+population-based+study+in+China&rft.jtitle=British+journal+of+cancer&rft.au=Hsing%2C+A+W&rft.au=Gao%2C+Y-T&rft.au=Han%2C+T-Q&rft.au=Rashid%2C+A&rft.date=2007-12-03&rft.issn=0007-0920&rft.volume=97&rft.issue=11&rft.spage=1577&rft.epage=1582&rft_id=info:doi/10.1038%2Fsj.bjc.6604047&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-0920&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-0920&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-0920&client=summon |